Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis - PubMed (original) (raw)
. 2001 Jul 1;61(13):5024-7.
Affiliations
- PMID: 11431336
Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis
A Mialhe et al. Cancer Res. 2001.
Abstract
Tubulin, the dimeric subunit of microtubules, is a major cell protein that is centrally involved in cell division. Tubulin is subject to specific enzymatic posttranslational modifications including cyclic tyrosine removal and addition at the COOH terminus of the alpha-subunit. Tubulin is normally extensively tyrosinated in cycling cells. However, we have previously shown that detyrosinated tubulin accumulates in cancer cells during tumor progression in nude mice. Tubulin detyrosination, resulting from suppression of tubulin tyrosine ligase and the resulting unbalanced activity of tubulin-carboxypeptidase, apparently represents a strong selective advantage for cancer cells. We have now analyzed the occurrence and significance of tubulin detyrosination in human breast tumors. We studied a total of 134 breast cancer tumors from patients with or without known complications over a follow-up period of 31 +/- 10 months. The mean age of the patients at the time of diagnosis was 57 years. For each patient, detailed data concerning the histology and extension of the tumor were available. Tumor cells containing detyrosinated tubulin were visualized by immunohistochemical staining of paraffin-embedded tissue sections. Cancer cells with detyrosinated tubulin were observed in 53% of the tumors and were predominant in 19.4% of the tumors. Tubulin detyrosination correlated to a high degree of significance (P < 0.001) with a high Scarf-Bloom-Richardson (SBR) grade, a known marker of tumor aggressiveness. Among SBR grade 1 tumors, 3.8% were strongly positive for tubulin detyrosination compared with 65.4% of the SBR grade 3 tumors. The SBR component showing the strongest correlation with tubulin detyrosination was the mitotic score. In the entire patient population, neither the SBR grade nor the detyrosination index had significant prognostic value (P = 0.11, P = 0.27, respectively), whereas a combined index was significantly correlated with the clinical outcome (P = 0.02). A preliminary subgroup analysis indicated that tubulin detyrosination may define high- and low- risk groups in breast cancer tumors with an SBR grade of 2. Our study shows that tubulin detyrosination is a frequent occurrence in breast cancer, easy to detect, and linked to tumor aggressiveness.
Similar articles
- Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland PS, Platt-Higgins A, El-Tanani M, De Silva Rudland S, Barraclough R, Winstanley JH, Howitt R, West CR. Rudland PS, et al. Cancer Res. 2002 Jun 15;62(12):3417-27. Cancer Res. 2002. PMID: 12067984 - Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H. Nevalainen MT, et al. J Clin Oncol. 2004 Jun 1;22(11):2053-60. doi: 10.1200/JCO.2004.11.046. J Clin Oncol. 2004. PMID: 15169792 - Parthenolide inhibits tubulin carboxypeptidase activity.
Fonrose X, Ausseil F, Soleilhac E, Masson V, David B, Pouny I, Cintrat JC, Rousseau B, Barette C, Massiot G, Lafanechère L. Fonrose X, et al. Cancer Res. 2007 Apr 1;67(7):3371-8. doi: 10.1158/0008-5472.CAN-06-3732. Cancer Res. 2007. PMID: 17409447 - Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F, Ferrero-Poüs M, Trassard M, Hacène K, Phillips E, Tubiana-Hulin M, Le Doussal V. Spyratos F, et al. Cancer. 2002 Apr 15;94(8):2151-9. doi: 10.1002/cncr.10458. Cancer. 2002. PMID: 12001111 Review. - The third tubulin pool.
Lafanechère L, Job D. Lafanechère L, et al. Neurochem Res. 2000 Jan;25(1):11-8. doi: 10.1023/a:1007575012904. Neurochem Res. 2000. PMID: 10685599 Review.
Cited by
- The Tubulin Code: A Navigation System for Chromosomes during Mitosis.
Barisic M, Maiato H. Barisic M, et al. Trends Cell Biol. 2016 Oct;26(10):766-775. doi: 10.1016/j.tcb.2016.06.001. Epub 2016 Jun 22. Trends Cell Biol. 2016. PMID: 27344407 Free PMC article. Review. - Microtubules regulate GEF-H1 in response to extracellular matrix stiffness.
Heck JN, Ponik SM, Garcia-Mendoza MG, Pehlke CA, Inman DR, Eliceiri KW, Keely PJ. Heck JN, et al. Mol Biol Cell. 2012 Jul;23(13):2583-92. doi: 10.1091/mbc.E11-10-0876. Epub 2012 May 16. Mol Biol Cell. 2012. PMID: 22593214 Free PMC article. - Identification of a novel transcript isoform of the TTLL12 gene in human cancers.
Wen R, Xiao Y, Zhang Y, Yang M, Lin Y, Tang J. Wen R, et al. Oncol Rep. 2016 Dec;36(6):3172-3180. doi: 10.3892/or.2016.5135. Epub 2016 Sep 28. Oncol Rep. 2016. PMID: 27748896 Free PMC article. - Detyrosinated microtubule protrusions in suspended mammary epithelial cells promote reattachment.
Whipple RA, Cheung AM, Martin SS. Whipple RA, et al. Exp Cell Res. 2007 Apr 15;313(7):1326-36. doi: 10.1016/j.yexcr.2007.02.001. Epub 2007 Feb 7. Exp Cell Res. 2007. PMID: 17359970 Free PMC article. - Microtentacles tip the balance of cytoskeletal forces in circulating tumor cells.
Matrone MA, Whipple RA, Balzer EM, Martin SS. Matrone MA, et al. Cancer Res. 2010 Oct 15;70(20):7737-41. doi: 10.1158/0008-5472.CAN-10-1569. Epub 2010 Oct 5. Cancer Res. 2010. PMID: 20924109 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases